Search
for
Sort by
Research 31–60 of 356
- A Review of Metabolic Dysregulation in Lymphocytic Cicatricial Alopecia: Exploring the Connections and Therapeutic Implications
- Mitigating GLP-1–Related Dermatologic Adverse Effects through Methylene Blue’s Antioxidant Action
- Risk of Suicide, Hair Loss, and Aspiration with GLP1-Receptor Agonists and Other Diabetic Agents: A Real-World Pharmacovigilance Study
- GLP-1 RAs and Skin Health: Exploring Dermatologic Side Effects and Therapeutic Interventions
- Dermatologic Implications of GLP-1 Receptor Agonist Medications: A Comprehensive Review
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- GLP-1 Receptor Agonists: Beyond Their Pancreatic Effects
- Exploring the Role of GLP‐1 Agents in Managing Diabetic Foot Ulcers: A Narrative and Systematic Review
- Editorial: Exploring innovative therapies for rare inflammatory skin diseases
- current possible treatment approaches of Polycystic Ovary Syndrome (PCOS)
- Dermatological, Trichological and Quality of Life Consequences of GLP ‐1 Receptor Agonist‐Mediated Weight Loss: A US Cross‐Sectional Survey
- Associations Between GLP‐1 Receptor Agonists and Alopecia: A Multi‐Centre Retrospective Analysis and Public Interest Trends
- “From evidence to practice” – Insights from the multidisciplinary team on the optimal integration of GLP‐1 receptor agonists in obesity management services
- The Impact of GLP-1 Receptor Agonists on Hair: Beneficial Effects or Adverse Outcomes?
- Semaglutide and the Skin: An Overview of Current Evidence
- The Potential Utility of Tirzepatide for the Management of Polycystic Ovary Syndrome
- Antidiabetic Management Strategies for Treatment of Polycystic Ovarian Syndrome
- Endocrinologia e Medicina Estética Ed. X
- Dermatological adverse reactions and therapeutic potential of semaglutide, liraglutide and tirzepatide: Analysis of UK pharmacovigilance data and literature review
- Impact of Reducing Obesity in PCOS: Methods and Treatment Outcomes
- Metabolic syndrome – a new definition and management guidelines A joint position paper by the Polish Society of Hypertension, Polish Society for the Treatment of Obesity, Polish Lipid Association, Polish Association for Study of Liver, Polish Society of Family Medicine, Polish Society of Lifestyle Medicine, Division of Prevention and Epidemiology Polish Cardiac Society, “Club 30” Polish Cardiac Society, and Division of Metabolic and Bariatric Surgery Society of Polish Surgeons
- THE VICIOUS CYCLE OF POLYCYSTIC OVARY SYNDROME AND BINGE EATING DISORDER: A REVIEW OF METABOLIC, PSYCHOLOGICAL, AND IATROGENIC PATHWAYS
- Telogen Effluvium and Metabolic Stress in Modern Weight Loss Interventions: A Narrative Clinical Review
- Improvement of Recalcitrant Folliculitis Decalvans With Tirzepatide: A Case Report
- Metabolic syndrome — a new definition and management guidelines
- Dercum Disease: Exploratory Therapeutic Approaches in the Absence of Standardized Medical Treatment—A Single Center Case Series
- Alopecia and Semaglutide: Connecting the Dots for Patient Safety
- Blockbuster Weight-Loss Drugs Not Tied to Suicidality, Studies Show
- Non-Hormonal Treatment Options for Regulation of Menstrual Cycle in Adolescents with PCOS
- Women With Polycystic Ovary Syndrome: A Review of Susceptibility to Type 2 Diabetes